Disease Info Card

Extra-adrenal Paraganglioma

Information about Extra-adrenal Paraganglioma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Extra-adrenal Paraganglioma

Most recent studies have shown that Extra-adrenal Paraganglioma shares some biological mechanisms with adrenal-gland-neoplasms, carcinoma, carotid-body-paraganglioma, ear-neoplasms, glomus-jugulare-tumor, glomus-tumor, head-and-neck-neoplasms, hypertensive-disease, lung-neoplasms, malignant-neoplasms, malignant-paraganglionic-neoplasm, mediastinal-neoplasms, neoplasm-metastasis, neoplasms, neoplasms-multiple-primary, neurilemmoma, paraganglioma, pheochromocytoma, retroperitoneal-neoplasms, skull-neoplasms.

Among the many pathways, these few ones have gauged particular interests from scientists studying Extra-adrenal Paraganglioma, and have been seen in publications frequently: Angiogenesis, Catecholamine Secretion, Cell Proliferation, Dehiscence, Electron Transport, Electron Transport Chain, Excretion, Hemostasis, Hypersensitivity, Innervation, Invasive Growth, Localization, Pathogenesis, Pigmentation, Regulation Of Hormone Secretion, Secretion, Transport, Transposition, Tricarboxylic Acid Cycle

Quite a number of genes have been found to play important roles in Extra-adrenal Paraganglioma, such as CALCA, CRAT, ENO1, ENO2, GLMN, GLYAT, KIT, POMC, RET, SDHB, SDHC, SDHD, SDS, SDSL, SS18L1, SST, SYP, VHL, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.